Re Agreement

NMT Group PLC
17 September 2001

17 September 2001

New Medical Technology Announces Strategic 'Best Value' Partnership with
Allegiance Healthcare

New Medical Technology, Inc. (NMT Inc.), the manufacturer of retractable
devices to prevent needlestick injury, announced today that it has concluded a
mutual partnership agreement with Allegiance, a Cardinal Health company, for
the marketing of the NMT safety syringe on a nationwide basis across the
United States.  Allegiance, headquartered in Waukegan, Illinois, is America's
largest distributor of healthcare products to hospitals, clinics and other
healthcare institutions.  With over 700 sales executives, Allegiance has
access to virtually all hospitals across the United States.

NMT Inc. will be part of the Allegiance 'Best Value' programme.  This is a
highly focused marketing programme for products that Allegiance categorises as
being innovative and unique and market leader in their field. The NMT Safety
Syringe is the only automatically retractable safety syringe designated as '
Best Value' in the Allegiance safety catalogue.

The NMT safety syringe features automatic needle retraction technology that is
activated as the user depresses the plunger to inject medication.  After
having been automatically retracted, the needle is safely stored in the barrel
after use, virtually eliminating needlestick injuries. The NMT safety syringe
will be provided to Allegiance in both the 3cc size and a newly introduced 1cc
size.

NMT Inc. has already begun an extensive training programme with the staff at
Allegiance Healthcare to ensure they are fully aware of the safety aspects and
benefits of the NMT safety syringe.

It is estimated that healthcare workers in the United States experience nearly
3,000 inadvertent needlesticks every day. On 6 November 2000, President
Clinton signed the Federal Needlestick Safety and Prevention Act into law
after unanimous approval in Congress. This law mandates that health care
workers have access to safety-engineered sharps devices that provide added
protection against needlesticks and consequential disease transmission due to
bloodborne pathogens such as Hepatitis and HIV/AIDS.

Stephen J. Czick, President of NMT Inc., said:

'We are extremely encouraged by Allegiance choosing NMT Inc. as one of its key
partners in the supply of safety syringes.  This agreement demonstrates the
strength of our growing sales effort in the US and our continuing progress in
attracting major national distributors, hospital agreements, and state
contract awards.  The agreement with Allegiance is strategically important as
it will give NMT Inc. access to, and a large, focused selling organisation at,
virtually all hospitals and healthcare providers across the US.'

Enquiries:

NMT Group PLC

Roy Smith, Chief Executive Officer                     02380 646 783
Gerard Cassels Chief Financial Officer                 01506 445049

NMT Inc.
Steve J. Czick, President                              001 617 852 4396

Financial Dynamics
David Yates/Fiona Noblet                               020 7831 3113